Thursday, July 30, 2026 | 12:44 AM ISTहिंदी में पढें
Business Standard
Notification Icon
userprofile IconSearch

Page 10 - Coronavirus Vaccine

French govt calls on high-risk groups to get 2nd Covid booster shot

There is currently a subvariant that is spreading fast in France, French government spokesperson Olivier Veran underlined

French govt calls on high-risk groups to get 2nd Covid booster shot
Updated On : 02 Dec 2022 | 9:47 AM IST
Data story: India adds 275 new Covid cases; active tally sees net decline
Updated On : 02 Dec 2022 | 9:07 AM IST

Data story: India records 291 Covid cases in 24 hours; 2 new deaths

India has added 2,155 cases in the past 7 days

Data story: India records 291 Covid cases in 24 hours; 2 new deaths
Updated On : 02 Dec 2022 | 8:50 AM IST

World's 1st intra-nasal vaccine for Covid gets CDSCO nod for emergency use

On November 28, iNCOVACC - the intra-nasal vaccine received both Primary series and Heterologous booster approval, as per Bharat Biotech

World's 1st intra-nasal vaccine for Covid gets CDSCO nod for emergency use
Updated On : 02 Dec 2022 | 7:17 AM IST

With the flu season here, should you ask for an influenza vaccine?

Demand for flu vaccine weak in India; US facing worst season in a decade

With the flu season here, should you ask for an influenza vaccine?
Updated On : 01 Dec 2022 | 4:07 PM IST

Chinese vaccine plans spark hope for end of 'zero Covid' amid protests

A campaign to vaccinate the elderly has sparked hopes China might roll back severe anti-virus controls that prompted protesters to demand President Xi Jinping resign, but the country faces daunting hurdles and up to a year of hard work before zero COVID can end. Stock markets rose after the National Health Commission on Monday announced the long-awaited campaign. A low vaccination rate is one of the biggest obstacles to ending curbs that have confined millions of people to their homes, depressed the economy and kept most visitors out of China. Health officials did not say how long it might take. A vaccination campaign will require months and China also needs to build up its hospitals and work out a long-term virus strategy, health experts and economists warn. They say zero COVID is likely to stay in place until mid-2023 and possibly as late as 2024. China is in no place right now to move away from its zero-COVID' policy toward a living with COVID' policy, said Mark Williams, chief .

Chinese vaccine plans spark hope for end of 'zero Covid' amid protests
Updated On : 30 Nov 2022 | 5:33 PM IST

Congress takes dig at PM Modi over deaths due to Covid-19 vaccines

The Congress on Wednesday took a swipe at Prime Minister Narendra Modi for "shrugging away" from its responsibility, a day after the government told the Supreme Court that it cannot be held liable to compensate for the deaths post administration of Covid vaccines. "First: No deaths due to oxygen shortage. Then: No aid to Covid victims. Now: No accountability for vaccine-related deaths. "Prime Minister Modi really knows how to shrug away responsibility. A true event manager!" the Congress said on its Twitter handle. Congress spokesperson Supriya Shrinate also took a dig, saying this government is never responsible for anything. "If there is death due to the side effects of Covid vaccine anywhere in the country, then the government is not responsible for it people are getting it as per their wish. This is Modi government's affidavit in the Supreme Court. (Well this government is never responsible for anything)," she said in a tweet in Hindi. In another tweet, she said, "Thank you M

Congress takes dig at PM Modi over deaths due to Covid-19 vaccines
Updated On : 30 Nov 2022 | 5:31 PM IST

Cannot be asked to compensate for deaths due to Covid-19 vaccines: Centre

The government cannot be held liable to compensate for the deaths due to an adverse event following immunisation (AEFI) post administration of Covid-19 vaccines, the Centre has told the Supreme Court. The affidavit filed in the apex court by the Centre assumes significance in view of the fact that the government has been zealously pursuing the Covid-19 vaccination programme to fight the pandemic and, as per latest reports, over 219 crore doses have been administered. The affidavit was filed in response to a petition by the parents of two girls who died allegedly due to adverse effects following Covid vaccination. It claimed vaccines manufactured by third parties had successfully undergone regulatory review, and holding the state directly liable to provide compensation may not be legally sustainable. "The vaccines in use under the vaccination program are manufactured by third parties and have successfully undergone thorough regulatory review in India as well as other nations, being

Cannot be asked to compensate for deaths due to Covid-19 vaccines: Centre
Updated On : 29 Nov 2022 | 11:22 PM IST

Bharat Bio looks for partners to manufacture, distribute iNCOVACC globally

Its local production ramp-up remains unhurried as demand for boosters reduces

Bharat Bio looks for partners to manufacture, distribute iNCOVACC globally
Updated On : 29 Nov 2022 | 10:17 PM IST

LIVE: All hospital services continue to run on manual mode at AIIMS

Live news updates: Catch all the latest news from around the world here

LIVE: All hospital services continue to run on manual mode at AIIMS
Updated On : 29 Nov 2022 | 9:45 PM IST

No legal compulsion to get Covid-19 vaccination, Centre tells SC

The Centre clarified to the Supreme Court that there was no legal compulsion to get a vaccination for COVID-19.

No legal compulsion to get Covid-19 vaccination, Centre tells SC
Updated On : 29 Nov 2022 | 4:09 PM IST
Data story: India adds 215 new Covid cases, active tally declines to 4,982
Updated On : 29 Nov 2022 | 9:40 AM IST
Data story: India records 291 new Covid cases, death toll reaches 530,614
Updated On : 29 Nov 2022 | 9:32 AM IST

Govt can't be held liable for deaths from Covid vaccine: Centre to SC

The Centre also emphasised that there is no legal compulsion to get Covid-19 vaccine

Govt can't be held liable for deaths from Covid vaccine: Centre to SC
Updated On : 29 Nov 2022 | 6:48 AM IST

Don't ignore Covid

The vaccination programme needs to be updated and revised

Don't ignore Covid
Updated On : 28 Nov 2022 | 10:51 PM IST

Bharat Biotech gets nasal vaccine nod for use as mix-match booster

iNCOVACC first intranasal Covid shot to receive approval for primary 2-dose schedule, heterologous booster us

Bharat Biotech gets nasal vaccine nod for use as mix-match booster
Updated On : 28 Nov 2022 | 10:40 PM IST

China logs 39,452 new Covid cases amid renewed protests against lockdowns

The protests against COVID-19 lockdowns have spread to Beijing even as China reported close to 40,000 coronavirus cases on Monday as authorities scrambled to contain the fresh surge in infections. For the fifth consecutive day, China reported close to 4,000 cases in the capital city of Beijing. China's National Health Commission said 39,452 new cases were reported on Monday, including 36,304 local asymptomatic cases. Meanwhile, the protests which broke out in the eastern metropolis of Shanghai during the weekend, have spread to Beijing where hundreds of people converged on Sunday evening near Liangmahe river in the central city. Crowds carrying lighted candles in memory of those killed in the fire at an apartment block reported under COVID-19 lockdown in Urumqi in Xinjiang shouted slogans against the arbitrary lockdowns by the government to curb the spread of the virus and in solidarity with the weekend protests in Shanghai. Several diplomats and foreigners watched the protests as

China logs 39,452 new Covid cases amid renewed protests against lockdowns
Updated On : 28 Nov 2022 | 12:23 PM IST

As China intensifies Covid-19 lockdowns, India gradually opens up

Data shows that spike in one country has not coincided with a rise the other

As China intensifies Covid-19 lockdowns, India gradually opens up
Updated On : 25 Nov 2022 | 11:46 PM IST

Bharat Biotech's Intranasal Covid booster gets DCGI nod for restricted use

As per the vaccine manufacturer, the nasal route has excellent potential for vaccination due to the organised immune systems of the nasal mucosa

Bharat Biotech's Intranasal Covid booster gets DCGI nod for restricted use
Updated On : 25 Nov 2022 | 4:37 PM IST

Data story: India records 347 new Covid cases; active tally at 5,516

With 3 new deaths, its Covid-19 death toll reached 530,604

Data story: India records 347 new Covid cases; active tally at 5,516
Updated On : 25 Nov 2022 | 9:17 AM IST